SEC Form 4 · accession 0001209191-17-049649
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Boyd
Officer — President and CFO
Period of report
Aug 15, 2017
Accepted (ET)
Aug 18, 2017 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Aug 15, 2017 | A | 150,000 | A | — | — | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock.
- F2The restricted stock units vest with respect to 1/36 of the total shares subject to the grant monthly for 36 months.